Mark G Thompson
Overview
Explore the profile of Mark G Thompson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
152
Citations
5294
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhong S, Thompson M, Cowling B
Influenza Other Respir Viruses
. 2025 Mar;
19(3):e70052.
PMID: 40045876
Background: Influenza vaccination is recommended annually based on the evolving nature of influenza viruses and the waning of vaccine-induced immunity. The timing of vaccination is usually before the winter influenza...
2.
Park J, Bartzoka F, von Beck T, Li Z, Mishina M, Hebert L, et al.
Lancet Microbe
. 2024 Dec;
6(2):100935.
PMID: 39667375
Background: Egg-based inactivated quadrivalent seasonal influenza vaccine (eIIV4), cell culture-based inactivated quadrivalent seasonal influenza vaccine (ccIIV4), and recombinant haemagglutinin (HA)-based quadrivalent seasonal influenza vaccine (RIV4) have been licensed for use...
3.
Fowlkes A, Peretz A, Greenberg D, Hirsch A, Martin E, Levine M, et al.
Int J Infect Dis
. 2024 Oct;
149:107260.
PMID: 39395753
Objectives: Trivalent inactivated influenza vaccine effectiveness was low in a prospective cohort of healthcare personnel (HCP) in Israel from 2016 to 2019. We conducted a randomised immunogenicity trial of quadrivalent...
4.
Liu F, Gross F, Joshi S, Gaglani M, Naleway A, Murthy K, et al.
Nat Commun
. 2024 Jan;
15(1):254.
PMID: 38177116
Repeat vaccination with egg-based influenza vaccines could preferentially boost antibodies targeting the egg-adapted epitopes and reduce immunogenicity to circulating viruses. In this randomized trial (Clinicaltrials.gov: NCT03722589), sera pre- and post-vaccination...
5.
DeSilva M, Knowlton G, Rai N, Bodurtha P, Essien I, Riddles J, et al.
J Community Health
. 2023 Dec;
49(3):448-457.
PMID: 38066221
COVID-19 disproportionately affects people experiencing homelessness or incarceration. While homelessness or incarceration alone may not impact vaccine effectiveness, medical comorbidities along with social conditions associated with homelessness or incarceration may...
6.
Zhong S, Ng T, Skowronski D, Iuliano A, Leung N, Perera R, et al.
J Infect Dis
. 2023 Nov;
229(5):1451-1459.
PMID: 37950884
Background: Annual influenza vaccination is recommended for older adults but repeated vaccination with standard-dose influenza vaccine has been linked to reduced immunogenicity and effectiveness, especially against A(H3N2) viruses. Methods: Community-dwelling...
7.
Azziz-Baumgartner E, Neyra J, Yau T, Soto G, Owusu D, Zhang C, et al.
Influenza Other Respir Viruses
. 2023 Sep;
17(9):e13189.
PMID: 37693773
Background: Uncertainty about risk of illness and the value of influenza vaccines negatively affects vaccine uptake among persons targeted for influenza vaccination. Methods: During 2016-2019, we followed a cohort of...
8.
Embi P, Levy M, Patel P, DeSilva M, Gaglani M, Dascomb K, et al.
Vaccine
. 2023 Jul;
41(37):5424-5434.
PMID: 37479609
Background: Immunocompromised (IC) persons are at increased risk for severe COVID-19 outcomes and are less protected by 1-2 COVID-19 vaccine doses than are immunocompetent (non-IC) persons. We compared vaccine effectiveness...
9.
Adams K, Riddles J, Rowley E, Grannis S, Gaglani M, Fireman B, et al.
Lancet Reg Health Am
. 2023 Jun;
23:100530.
PMID: 37333688
Background: Understanding the usefulness of additional COVID-19 vaccine doses-particularly given varying disease incidence-is needed to support public health policy. We characterize the benefits of COVID-19 booster doses using number needed...
10.
Biggs H, Simoes E, Khader I, Thompson M, Gordon A, Hunt D, et al.
J Pediatric Infect Dis Soc
. 2023 Jun;
12(7):394-405.
PMID: 37313727
Background: Understanding respiratory syncytial virus (RSV) global epidemiology is important to inform future prevention strategies. Methods: Hospitalized infants <1-year-old with acute illness were enrolled prospectively in Albania, Jordan, Nicaragua, and...